IL96776A - Antibacterial compositions containing quinolone carboxylic acid-metal ion-acid complexes - Google Patents

Antibacterial compositions containing quinolone carboxylic acid-metal ion-acid complexes

Info

Publication number
IL96776A
IL96776A IL9677690A IL9677690A IL96776A IL 96776 A IL96776 A IL 96776A IL 9677690 A IL9677690 A IL 9677690A IL 9677690 A IL9677690 A IL 9677690A IL 96776 A IL96776 A IL 96776A
Authority
IL
Israel
Prior art keywords
quinolone carboxylic
metal ion
acid
carboxylic acid
compositions containing
Prior art date
Application number
IL9677690A
Other languages
English (en)
Other versions
IL96776A0 (en
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23822659&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL96776(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of IL96776A0 publication Critical patent/IL96776A0/xx
Publication of IL96776A publication Critical patent/IL96776A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F3/00—Compounds containing elements of Groups 2 or 12 of the Periodic Table
    • C07F3/003—Compounds containing elements of Groups 2 or 12 of the Periodic Table without C-Metal linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/06—Aluminium compounds
    • C07F5/069—Aluminium compounds without C-aluminium linkages

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL9677690A 1989-12-29 1990-12-24 Antibacterial compositions containing quinolone carboxylic acid-metal ion-acid complexes IL96776A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US45892789A 1989-12-29 1989-12-29

Publications (2)

Publication Number Publication Date
IL96776A0 IL96776A0 (en) 1991-09-16
IL96776A true IL96776A (en) 1997-02-18

Family

ID=23822659

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9677690A IL96776A (en) 1989-12-29 1990-12-24 Antibacterial compositions containing quinolone carboxylic acid-metal ion-acid complexes

Country Status (14)

Country Link
US (1) US5334589A (de)
EP (1) EP0507851B1 (de)
JP (1) JP3153549B2 (de)
AT (1) ATE150973T1 (de)
AU (1) AU647772B2 (de)
CA (1) CA2072366C (de)
DE (1) DE69030387T2 (de)
DK (1) DK0507851T3 (de)
ES (1) ES2102393T3 (de)
GR (1) GR3023542T3 (de)
IE (1) IE904725A1 (de)
IL (1) IL96776A (de)
PT (1) PT96400B (de)
WO (1) WO1991009525A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9118183D0 (en) * 1991-08-23 1991-10-09 Solanki Kishor K Imaging of infections
US5290794A (en) * 1992-10-27 1994-03-01 Warner Lambert Co. Soluble calcium lactate antibacterial complexes as non-irritating parenteral forms
US6024979A (en) * 1995-06-06 2000-02-15 Solvay Animal Health, Inc. Oral veterinary composition containing a fluoroquinolone antibacterial agent possessing superior absorption properties and an extended duration of therapeutic antimicrobial blood levels, and a method of treating a microbial infection in a ruminant
EP0868183B1 (de) * 1995-12-21 2002-01-30 Pfizer Inc. Injizierbare quinolonformulierungen
ID21415A (id) 1997-12-05 1999-06-10 Upjohn Co Senyawa-senyawa antibiotik magnesium quinolon
DE19937115A1 (de) 1999-08-06 2001-02-08 Bayer Ag Wäßrige Arzneimittelformulierung von Moxifloxacin oder Salzen davon
DE19937116A1 (de) 1999-08-06 2001-02-08 Bayer Ag Moxifloxacin Kochsalzformulierung
DE10018781A1 (de) * 2000-04-15 2001-10-25 Fresenius Kabi De Gmbh Infusionslösungen des Ciprofloxacins mit verbesserter Lagerfähigkeit
AU2005258398A1 (en) * 2004-07-02 2006-01-12 Daiichi Pharmaceutical Co., Ltd. Quinolone-containing medicinal composition
US7838532B2 (en) * 2005-05-18 2010-11-23 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
US8546423B2 (en) 2005-05-18 2013-10-01 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
US20070197548A1 (en) * 2006-02-17 2007-08-23 Murthy Yerramilli V S Fluoroquinolone compositions
DE102006010643A1 (de) * 2006-03-08 2007-09-13 Bayer Healthcare Aktiengesellschaft Arzneimittel enthaltend Fluorchinolone
KR101959873B1 (ko) 2008-10-07 2019-03-19 랩터 파마슈티컬스 인코포레이티드 약동학 개선을 위한 에어로졸 플루오로퀴놀론 제형
CA2739893C (en) 2008-10-07 2016-10-04 Mpex Pharmaceuticals, Inc. Inhalation of levofloxacin for reducing lung inflammation
WO2011029059A1 (en) 2009-09-04 2011-03-10 Mpex Pharmaceuticals, Inc. Use of aerosolized levofloxacin for treating cystic fibrosis
WO2016195020A1 (ja) 2015-06-02 2016-12-08 杏林製薬株式会社 水性液剤
JP6031217B1 (ja) 2015-06-02 2016-11-24 杏林製薬株式会社 水性液剤
JP6031216B1 (ja) 2015-06-02 2016-11-24 杏林製薬株式会社 水性液剤
CN105524060B (zh) * 2016-03-10 2017-03-22 青岛云天生物技术有限公司 一种制备盐酸莫西沙星的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4730000A (en) * 1984-04-09 1988-03-08 Abbott Laboratories Quinoline antibacterial compounds
NZ208470A (en) * 1983-07-18 1988-06-30 Abbott Lab 6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid derivatives and antibacterial compositions containing such
DE3333719A1 (de) * 1983-09-17 1985-04-04 Bayer Ag Loesungen milchsaurer salze von piperazinylchinolon- und piperazinyl-azachinoloncarbonsaeuren
DE3713672A1 (de) * 1987-04-24 1988-11-17 Bayer Ag Verfahren zur herstellung von parenteral verabreichbaren chinoloncarbonsaeuren
JP2832535B2 (ja) * 1989-04-04 1998-12-09 富山化学工業株式会社 キノロンカルボン酸またはその塩の可溶化法
FR2665635A1 (fr) * 1990-08-10 1992-02-14 Merck Sharp & Dohme Composition pharmaceutique fluide a base d'un complexe metallique et son procede de preparation.

Also Published As

Publication number Publication date
AU647772B2 (en) 1994-03-31
AU7153191A (en) 1991-07-24
JP3153549B2 (ja) 2001-04-09
DE69030387T2 (de) 1997-10-23
WO1991009525A1 (en) 1991-07-11
DE69030387D1 (de) 1997-05-07
CA2072366A1 (en) 1991-06-30
IL96776A0 (en) 1991-09-16
JPH05502879A (ja) 1993-05-20
IE904725A1 (en) 1991-07-17
US5334589A (en) 1994-08-02
EP0507851B1 (de) 1997-04-02
EP0507851A4 (en) 1993-03-17
ES2102393T3 (es) 1997-08-01
CA2072366C (en) 2002-08-20
DK0507851T3 (da) 1997-08-25
ATE150973T1 (de) 1997-04-15
EP0507851A1 (de) 1992-10-14
GR3023542T3 (en) 1997-08-29
PT96400B (pt) 1998-06-30
PT96400A (pt) 1991-10-15

Similar Documents

Publication Publication Date Title
IL96776A (en) Antibacterial compositions containing quinolone carboxylic acid-metal ion-acid complexes
ATE73657T1 (de) Verwendung von gamma-linolensaeure und verwandten verbindungen zur herstellung eubnes arzneimittels zur behandlung von endometriose.
MY110734A (en) Improvements in or relating to dioic acids.
UA41502C2 (uk) Стабілізований фармацевтичний препарат, який містить гормон росту і гістидин, кристали гормону росту, що містять гістидин, та спосіб їх одержання
IL103303A (en) Pharmaceutical compositions containing ibuprofen and codeine for relief of chronic pain
IE882091L (en) Pharmaceutical compositions comprising sometostatin¹analogues
DE69521536D1 (de) Zusammensetzungen die G-CSF und ein TNF-Bindungsprotein enthalten
IL86862A (en) Pharmaceutical compositions for reducing the level of circulating immune complexes in vivo, containing mismatched double-stranded rna
ES8500931A1 (es) Procedimiento para la obtencion de acidos quinoloncarboxilicos
UA60352C2 (uk) Синтетичні полісахариди та фармацевтична композиція, що їх містить
DE3880587D1 (de) Verwendung von bestimmten calcium-citrate-malaten zur herstellung einer pharmazeutischen zubereitung fuer die behandlung von osteoporose.
GR3015722T3 (en) Pharmaceutical uses of fatty acids.
EP0414806A4 (en) High ratio active agent:lipid complex
GR3001565T3 (en) Medical preparation comprising aspoxicillin, a method for its preparation, and the use of such a preparation for the manufacture of a medicament
HUT73500A (en) Use of benzydamine for producing pharmaceutical compositions for treatment of pathological conditions caused by tnf
DE69941459D1 (de) Verfahren zur herstellung von essbaren zusammenstellungen mit antibakteriellen wirkstoffen
ATE173925T1 (de) Lösliche calciumlaktat/chinoloncarbonsäuren komplexe als nichtreizende parenterale verabreichungsformen
HU911272D0 (en) Process for the production of medical preparations containing hexetidine
EP0621789A4 (en) Pharmaceutical pentapeptide compositions and methods of use thereof.
IL103499A0 (en) Pharmaceutical compositions for treating anxiety in benzodiazepine withdrawn patients
UA10219A (uk) Спосіб лікування туберкульозу легень
UA19647A (uk) Спосіб лікуваhhя остеомієліту щелепи

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired